BPC-157 + TB-500 — 20 mg
Combination of BPC-157 (pentadecapeptide) and TB-500 (thymosin β4 fragment). A two-peptide combination studied in preclinical tissue-repair models for angiogenesis, cell migration, and cytoprotection.
Research Focus:
Blood Vessel Formation Research — Studied for angiogenic VEGFR2 signaling.
Tissue Repair Research — Investigated for repair-pathway activity.
Cell Migration Research — TB-500 studied for G-actin binding and migration.
Cell Protection Research — BPC-157 examined for cytoprotective signaling.
Inflammation Research — Examined for inflammatory-modulation in repair models.
Tissue Structure Research — Studied for ECM interaction during repair.
Regenerative Research — Studied within tissue-regeneration research.
Mucosal Healing Research — BPC-157 studied within gastrointestinal mucosal-repair research models.
RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
Not for human or veterinary use. Sold exclusively as a reference material for in-vitro and in-vivo laboratory research. Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.
